AMN Healthcare Services financials
$34.95+2.01%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $673.2M | $1.38B | $748.2M | $634.5M | $658.2M | $689.5M | $734.7M | $687.5M | $740.7M | $820.9M | $818.3M | $853.5M |
| Gross profit | $205.9M | $368.8M | $195.1M | $184.4M | $196.4M | $198.1M | $219.0M | $213.1M | $229.8M | $257.5M | $260.9M | $289.5M |
| Gross margin | 30.6% | 26.8% | 26.1% | 29.1% | 29.8% | 28.7% | 29.8% | 31.0% | 31.0% | 31.4% | 31.9% | 33.9% |
| Operating income | $26.9M | $117.2M | -$31.0M | $47.6M | -$123.7M | $12.5M | -$202.6M | $22.3M | $37.7M | $39.9M | $34.2M | $86.9M |
| Net income | $21.2M | $62.2M | -$7.7M | $29.3M | -$116.2M | -$1.1M | -$187.5M | $7.0M | $16.2M | $17.3M | $12.5M | $53.2M |
| Net margin | 3.1% | 4.5% | −1.0% | 4.6% | −17.7% | −0.2% | −25.5% | 1.0% | 2.2% | 2.1% | 1.5% | 6.2% |
| Diluted EPS | $0.53 | $1.59 | $-0.20 | $0.76 | $-3.02 | $-0.03 | $-4.93 | $0.18 | $0.42 | $0.45 | $0.33 | $1.39 |
| EBITDA | $61.0M | $152.8M | $6.2M | $87.2M | $43.9M | $52.4M | $61.4M | $65.3M | $82.4M | $84.5M | $34.2M | $127.7M |
| Operating cash flow | -$189.9M | $562.5M | $75.6M | $22.7M | $78.5M | $92.7M | $72.8M | $66.7M | $99.5M | $81.4M | -$38.7M | $169.8M |
| Free cash flow | -$198.5M | $555.2M | $67.6M | $14.8M | $68.7M | $82.7M | $56.6M | $47.4M | $72.2M | $63.2M | -$68.6M | $139.9M |
| Diluted shares | 39.7M | 39.1M | 38.7M | 38.7M | 38.4M | 38.3M | 38.0M | 38.3M | 38.2M | 38.2M | 38.1M | 38.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $361.8M | $560.7M | $34.0M | $52.6M | $41.5M | $55.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $742.9M | $742.5M | $767.1M | $846.8M | $916.5M | $996.2M |
| Total assets | $2.36B | $2.60B | $2.09B | $2.14B | $2.21B | $2.40B |
| Total liabilities | $1.62B | $1.89B | $1.45B | $1.49B | $1.60B | $1.68B |
| Shareholders' equity | $741.3M | $712.8M | $642.1M | $644.4M | $607.6M | $715.1M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology